CARD11-BCL10-MALT1 complex inhibitor XL114
Term · Oncology and biomedicine · MLC-T-ONC-012307
An orally bioavailable inhibitor of the caspase recruitment domain-containing protein 11 (CARD11; CARMA1)-B-cell lymphoma/leukemia 10 (BCL10)-mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1) complex, with potential antineoplastic activity. Upon oral administration, CARD11-BCL10-MALT1 complex inhibitor XL114 inhibits the CARD11-BCL10-MALT1 complex and the CARD11-BCL10-MALT1 signaling pathway. This prevents the proliferation of susceptible cancer cells. The CARD11-BCL10-MALT1 signaling pathway promotes B- and T-cell lymphoma survival and proliferation.
| Identifier | MLC-T-ONC-012307 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | CARD11-BCL10-MALT1 pathway inhibitor XL114; CARMA1-BCL10-MALT1 pathway inhibitor XL114 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012307",
"term": "CARD11-BCL10-MALT1 complex inhibitor XL114",
"field": "Oncology and biomedicine",
"definition": "An orally bioavailable inhibitor of the caspase recruitment domain-containing protein 11 (CARD11; CARMA1)-B-cell lymphoma/leukemia 10 (BCL10)-mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1) complex, with potential antineoplastic activity. Upon oral administration, CARD11-BCL10-MALT1 complex inhibitor XL114 inhibits the CARD11-BCL10-MALT1 complex and the CARD11-BCL10-MALT1 signaling pathway. This prevents the proliferation of susceptible cancer cells. The CARD11-BCL10-MALT1 signaling pathway promotes B- and T-cell lymphoma survival and proliferation.",
"synonyms": [
"CARD11-BCL10-MALT1 pathway inhibitor XL114",
"CARMA1-BCL10-MALT1 pathway inhibitor XL114"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/card11-bcl10-malt1-complex-inhibitor-xl114/"
}
Record 4,236 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.